In vivo molecular skin fluorescence imaging for noninvasive assessment of atypical nevi and melanoma: A validation trial
SFI demonstrated high sensitivity and specificity for discriminating low-risk from high-risk lesions, representing a promising approach to enhance evaluation of clinically concerning pigmented lesions and reduce unnecessary biopsies.
Authors
- Kevin Manbeck
- Justin Ko (ORCID: https://orcid.org/0000-0003-4232-5906)
- Sunil S. Dhawan
- Douglas Grossman (ORCID: https://orcid.org/0000-0003-1790-7023)
- Sancy Ann Leachman (ORCID: https://orcid.org/0000-0001-9140-0648)
- Elizabeth Berry (ORCID: https://orcid.org/0000-0002-7574-6718)
- Serena Mraz
- Catherine M. Shachaf (ORCID: https://orcid.org/0000-0002-8178-5166)
- Amit Shachaf
- Raja Sivamani
- Shamika Majmudar
Institutions
- Oregon Health & Science University (US)
- University of Utah (US)
- Huntsman Cancer Institute (US)
- Sensors (United States) (US)
- Sutter Solano Medical Center (US)
- Cosmetic Laser Dermatology (US)
- Center for Dermatology, Cosmetic & Laser Surgery (US)
- Stanford University (US)
Publication Details
- Journal
- JAAD International
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1016/j.jdin.2025.11.010
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00